Tumor-Targeting of EGFR Inhibitors by Hypoxia-Mediated Activation

Claudia Karnthaler-Benbakka, Diana Groza, Kushtrim Kryeziu, Verena Pichler, Alexander Roller, Walter Berger, Petra Heffeter (Corresponding author), Christian R. Kowol

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)12930-12935
Number of pages6
JournalAngewandte Chemie (International Edition)
Volume53
Issue number47
DOIs
Publication statusPublished - 17 Nov 2014

Austrian Fields of Science 2012

  • 104003 Inorganic chemistry
  • 301904 Cancer research

Keywords

  • anticancer drugs
  • cobalt
  • hypoxia
  • prodrugs
  • tyrosine-kinase inhibitors
  • RECEPTOR TYROSINE KINASE
  • METAL-COMPLEXES
  • CANCER
  • PRODRUG
  • DERIVATIVES
  • THERAPY
  • AGENTS
  • Prodrugs
  • Anticancer drugs
  • Tyrosine-kinase inhibitors
  • Cobalt
  • Hypoxia

Fingerprint

Dive into the research topics of 'Tumor-Targeting of EGFR Inhibitors by Hypoxia-Mediated Activation'. Together they form a unique fingerprint.

Cite this